Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy

Revision as of 18:44, 21 April 2014 by Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Bleeding}} {{Main|Bleeding}} {{CMG}} ==2013 ESA Guidelines for the Management of Severe Perioperative Bleeding (DO NOT EDIT)<ref name="Kozek-Langenecker-2013">{{C...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Bleeding Microchapters

Home

Patient Information

Overview

Classification

Bleeding Academic Research Consortium
TIMI bleeding criteria
GUSTO bleeding criteria
CURE bleeding criteria
ACUITY HORIZONS bleeding criteria
STEEPLE bleeding criteria
PLATO bleeding criteria
GRACE bleeding criteria

Causes

Treatment

Emergency Bleeding Control

Reversal of Anticoagulation and Antiplatelet in Active Bleed

Perioperative Bleeding

Anemia Management
Coagulation Monitoring
Coagulation Management
Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy
Antiplatelet Agents
Heparin
Fondaparinux
Vitamin K Antagonists
New Oral Anticoagulants
Comorbidities Involving Hemostatic Derangement
Specific Surgeries
Cardiovascular Surgery
Gynecological Bleeding
Obstetric Bleeding
Orthopedic/Neurosurgery
Visceral/Transplant Surgery
Pediatric Surgery
Congenital Bleeding Disorders
von Willebrand Disease
Platelet Defects
Hemophilia A and B
Factor VII Deficiency
Rare Bleeding Disorders

Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy

CDC on Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy

Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy in the news

Blogs on Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy

Directions to Hospitals Treating Bleeding

Risk calculators and risk factors for Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

2013 ESA Guidelines for the Management of Severe Perioperative Bleeding (DO NOT EDIT)[1]

Sources

  • 2013 ESA Guidelines for the Management of Severe Perioperative Bleeding[1]

References

  1. 1.0 1.1 Kozek-Langenecker, SA.; Afshari, A.; Albaladejo, P.; Santullano, CA.; De Robertis, E.; Filipescu, DC.; Fries, D.; Görlinger, K.; Haas, T. (2013). "Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology". Eur J Anaesthesiol. 30 (6): 270–382. doi:10.1097/EJA.0b013e32835f4d5b. PMID 23656742. Unknown parameter |month= ignored (help)